Literature DB >> 32603776

Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories.

Brian J Lopresti1, Elizabeth M Campbell2, Zheming Yu2, Stewart J Anderson3, Ann D Cohen4, Davneet S Minhas2, Beth E Snitz5, Sarah K Royse2, Carl R Becker2, Howard J Aizenstein4, Chester A Mathis2, Oscar L Lopez5, William E Klunk4, Dana L Tudorascu6.   

Abstract

To characterize the influence of apolipoprotein-E (APOE) genotype on cerebral Aβ load and longitudinal Aβ trajectories, [11C]Pittsburgh compound-B (PiB) positron emission tomography (PET) imaging was used to assess amyloid load in a clinically heterogeneous cohort of 428 elderly participants with known APOE genotype. Serial [11C]PiB data and a repeated measures model were used to model amyloid trajectories in a subset of 235 participants classified on the basis of APOE genotype. We found that APOE-ε4 was associated with increased Aβ burden and an earlier age of onset of Aβ positivity, whereas APOE-ε2 appeared to have modest protective effects against Aβ. APOE class did not predict rates of Aβ accumulation. The present study suggests that APOE modifies Alzheimer's disease risk through a direct influence on amyloidogenic processes, which manifests as an earlier age of onset of Aβ positivity, although it is likely that other genetic, environmental, and lifestyle factors are important.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyloid; Apolipoprotein-E; Genetics; Positron emission tomography (PET)

Mesh:

Substances:

Year:  2020        PMID: 32603776      PMCID: PMC7483397          DOI: 10.1016/j.neurobiolaging.2020.05.012

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  60 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Amyloid imaging in dementias with atypical presentation.

Authors:  David A Wolk; Julie C Price; Charles Madeira; Judy A Saxton; Beth E Snitz; Oscar L Lopez; Chester A Mathis; William E Klunk; Steven T DeKosky
Journal:  Alzheimers Dement       Date:  2012-01-30       Impact factor: 21.566

3.  APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.

Authors:  John C Morris; Catherine M Roe; Chengjie Xiong; Anne M Fagan; Alison M Goate; David M Holtzman; Mark A Mintun
Journal:  Ann Neurol       Date:  2010-01       Impact factor: 10.422

4.  Comparison of longitudinal Aβ in nondemented elderly and Down syndrome.

Authors:  Dana L Tudorascu; Stewart J Anderson; Davneet S Minhas; Zheming Yu; Diane Comer; Patrick Lao; Sigan Hartley; Charles M Laymon; Beth E Snitz; Brian J Lopresti; Sterling Johnson; Julie C Price; Chester A Mathis; Howard J Aizenstein; William E Klunk; Benjamin L Handen; Brad T Christian; Ann D Cohen
Journal:  Neurobiol Aging       Date:  2018-09-27       Impact factor: 4.673

5.  Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.

Authors:  Ann D Cohen; Julie C Price; Lisa A Weissfeld; Jeffrey James; Bedda L Rosario; Wenzhu Bi; Robert D Nebes; Judith A Saxton; Beth E Snitz; Howard A Aizenstein; David A Wolk; Steven T Dekosky; Chester A Mathis; William E Klunk
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

6.  Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians.

Authors:  C M Morris; R Benjamin; A Leake; F K McArthur; J M Candy; P G Ince; A Torvik; E Bjertness; J A Edwardson
Journal:  Neurosci Lett       Date:  1995-12-01       Impact factor: 3.046

7.  Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

Authors:  A M Saunders; W J Strittmatter; D Schmechel; P H George-Hyslop; M A Pericak-Vance; S H Joo; B L Rosi; J F Gusella; D R Crapper-MacLachlan; M J Alberts
Journal:  Neurology       Date:  1993-08       Impact factor: 9.910

8.  Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease.

Authors:  Z Nagy; M M Esiri; K A Jobst; C Johnston; S Litchfield; E Sim; A D Smith
Journal:  Neuroscience       Date:  1995-12       Impact factor: 3.590

9.  Frequent amyloid deposition without significant cognitive impairment among the elderly.

Authors:  Howard Jay Aizenstein; Robert D Nebes; Judith A Saxton; Julie C Price; Chester A Mathis; Nicholas D Tsopelas; Scott K Ziolko; Jeffrey A James; Beth E Snitz; Patricia R Houck; Wenzhu Bi; Ann D Cohen; Brian J Lopresti; Steven T DeKosky; Edythe M Halligan; William E Klunk
Journal:  Arch Neurol       Date:  2008-11

10.  Protective effects of APOE e2 against disease progression in subcortical vascular mild cognitive impairment patients: A three-year longitudinal study.

Authors:  Yeo Jin Kim; Sang Won Seo; Seong Beom Park; Jin Ju Yang; Jin San Lee; Juyoun Lee; Young Kyoung Jang; Sung Tae Kim; Kyung-Han Lee; Jong Min Lee; Jae-Hong Lee; Jae Seung Kim; Duk L Na; Hee Jin Kim
Journal:  Sci Rep       Date:  2017-05-15       Impact factor: 4.379

View more
  7 in total

1.  Predictive Scale for Amyloid PET Positivity Based on Clinical and MRI Variables in Patients with Amnestic Mild Cognitive Impairment.

Authors:  Min Young Chun; Geon Ha Kim; Hee Kyung Park; Dong Won Yang; SangYun Kim; Seong Hye Choi; Jee Hyang Jeong
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

2.  Relationship between amyloid and tau levels and its impact on tau spreading.

Authors:  Vincent Doré; Natasha Krishnadas; Pierrick Bourgeat; Kun Huang; Shenpeng Li; Samantha Burnham; Colin L Masters; Jurgen Fripp; Victor L Villemagne; Christopher C Rowe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-26       Impact factor: 9.236

3.  Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET.

Authors:  Suzanne E Schindler; Yan Li; Virginia D Buckles; Brian A Gordon; Tammie L S Benzinger; Guoqiao Wang; Dean Coble; William E Klunk; Anne M Fagan; David M Holtzman; Randall J Bateman; John C Morris; Chengjie Xiong
Journal:  Neurology       Date:  2021-09-09       Impact factor: 11.800

4.  Imaging beta-amyloid (Aβ) burden in the brains of middle-aged individuals with alcohol-use disorders: a [11C]PIB PET study.

Authors:  Margaret R Flanigan; Sarah K Royse; David P Cenkner; Katelyn M Kozinski; Clara J Stoughton; Michael L Himes; Davneet S Minhas; Brian Lopresti; Meryl A Butters; Rajesh Narendran
Journal:  Transl Psychiatry       Date:  2021-05-01       Impact factor: 7.989

5.  Strategies to reduce sample sizes in Alzheimer's disease primary and secondary prevention trials using longitudinal amyloid PET imaging.

Authors:  Isadora Lopes Alves; Fiona Heeman; Lyduine E Collij; Gemma Salvadó; Nelleke Tolboom; Natàlia Vilor-Tejedor; Pawel Markiewicz; Maqsood Yaqub; David Cash; Elizabeth C Mormino; Philip S Insel; Ronald Boellaard; Bart N M van Berckel; Adriaan A Lammertsma; Frederik Barkhof; Juan Domingo Gispert
Journal:  Alzheimers Res Ther       Date:  2021-04-19       Impact factor: 6.982

6.  White matter microstructure disruption in early stage amyloid pathology.

Authors:  Lyduine E Collij; Silvia Ingala; Herwin Top; Viktor Wottschel; Kristine E Stickney; Jori Tomassen; Elles Konijnenberg; Mara Ten Kate; Carole Sudre; Isadora Lopes Alves; Maqsood M Yaqub; Alle Meije Wink; Dennis Van 't Ent; Philip Scheltens; Bart N M van Berckel; Pieter Jelle Visser; Frederik Barkhof; Anouk Den Braber
Journal:  Alzheimers Dement (Amst)       Date:  2021-04-01

7.  Risk of dementia in APOE ε4 carriers is mitigated by a polygenic risk score.

Authors:  Jarith L Ebenau; Sven J van der Lee; Marc Hulsman; Niccolò Tesi; Iris E Jansen; Inge M W Verberk; Mardou van Leeuwenstijn; Charlotte E Teunissen; Frederik Barkhof; Niels D Prins; Philip Scheltens; Henne Holstege; Bart N M van Berckel; Wiesje M van der Flier
Journal:  Alzheimers Dement (Amst)       Date:  2021-09-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.